The risk of monkeypox in the general population remains very low based on the information available. Long Beach Health is continuing to investigate and conduct contact tracing. For any close contact, Long Beach Health will monitor and coordinate post-exposure prevention for close contacts, as needed.


as of August 15, 2022

The JYNNEOS vaccine is extremely limited in the United States. As of August 2, vaccine is only available for the following groups in Long Beach: 

  • People who were exposed to someone with confirmed monkeypox and do not have symptoms.
  • People who attended an event/venue where there was high risk of exposure to someone with confirmed monkeypox.
  • Gay or bisexual men and transgender persons who are on HIV pre-exposure prophylaxis (PrEP).
  • Gay or bisexual men and transgender people who attended saunas, bathhouses, sex clubs, circuit parties or sex parties where they had anonymous sex or sex with multiple partners.
  • Gay or bisexual men and transgender people with a diagnosis of gonorrhea or early syphilis within the past 12 months.
  • Gay or bisexual men and transgender people 18 years of age and older who had multiple or anonymous sex partners in the last 14 days including engaging in survival and/or transactional sex (e.g., sex in exchange for shelter, food and other goods and needs).
  • Residents who are immunocompromised, including those with advanced or uncontrolled HIV, who may be at high risk for severe disease.

Long Beach Health Department will expand eligibility as additional vaccine is available. The federal government anticipates distributing additional doses later this month.  

The below pre-registration survey is available for individuals to join a vaccine waitlist. Those who sign-up and meet the new eligibility criteria will be contacted with additional information on how to get vaccinated when it is their turn.

(English and Spanish)

Monkeypox is an infectious disease that is caused by infection with monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus which includes the variola (smallpox) virus as well as the vaccinia virus, which is used in the smallpox vaccine.  Monkeypox is endemic to Central and West Africa, but as of May 2022 cases of monkeypox have been detected in various European countries and the United States, including California. There are currently no known cases in Long Beach. 

Monkeypox symptoms are similar to smallpox but less severe. Monkeypox may begin with fever, headache, muscle aches, and exhaustion. Within 1 to 3 days after fever, a rash develops which may last 2 to 4 weeks. Most people will recover on their own, but those who are immunocompromised may have severe disease and additional complications such as sepsis, pneumonia, encephalitis, and loss of vision. Once exposed to monkeypox, symptoms usually develop in 7-14 days, but can range from 5-21 days. 

Monkeypox can be spread from person to person through direct contact with body fluids or lesion, or contaminated materials such as clothing or linens, and through respiratory droplets though prolonged face to face contact. Medical countermeasures to prevent and/or treat monkeypox are available in the form of vaccines and antivirals (additional information below). 

To learn more about monkeypox, read our FAQ: English | Spanish | Khmer | Tagalog

This is a Monkeypox Rash on the back    This is a Monkeypox rash on thumb    This is a Monkeypox Rash on skin    This is a Monkeypox Rash on skin
Photo Credit: NHS England High Consequence Infectious Disease Network and UK Health Security Agency 

If you have symptoms and think you may have MPV, please call your healthcare provider who will determine the need for testing. If you do not have a healthcare provider and are experiencing symptoms, please contact the City of Long Beach’s public health information line at 562.570.7907 for assistance with finding healthcare services. For patients who test positive for MPV, your healthcare provider will determine the course of action for treatment.

People who may have symptoms of monkeypox should contact their healthcare providers. This includes anyone who:

  1. Traveled to an area where monkeypox cases or exposures have been reported 
  2. Had contact with a person who has a similar rash or received a diagnosis of confirmed or suspected monkeypox
  3. Had close or intimate in-person contact with individuals in a social network experiencing monkeypox activity, this includes men who have sex with men who meet partners through an online website, digital app, or social event
  4. Had contact with a dead or live wild animal or pet that is an African endemic species or used a product derived from such animals

There are steps individuals can take to protect themselves from monkeypox including: asking intimate and other sexual partners about symptoms, avoiding skin-to-skin or prolonged face-to-face contact with anyone who has symptoms, practicing safer sex (such as reducing the number of sexual partners), keeping hands clean, and maintaining respiratory etiquette.

To report a positive laboratory result for orthopox or monkeypox virus, immediately call the Communicable Disease Surveillance and Control Division at 562.570.4302 or fax laboratory results and patient information to 562.570.4374.

Healthcare providers should be alert and consider monkeypox virus in patients who present with an unexplained rash or lesions consistent with monkeypox:

  1. Instruct patient to isolate and avoid contact with other people while waiting for test results
  2. Submit specimens for monkeypox testing through commercial laboratories if possible. Testing is now available through commercial laboratories including:
    • Labcorp - Do not add any transport media to the sample. Two swabs from each lesion should be submitted to ensure adequate material is sampled.
    • Quest Diagnostics - Lesion swab collected in 3 mL of viral transport media (VTM)
    • ARUP Laboratories - Validated for both dry-swab specimen collection and for collection using viral transport media (VTM)
    • Aegis Sciences Corporation - Validated for both dry-swab specimen collection and for collection using viral transport media (VTM)
  3. TPOXX Protocol for Providers 

Specimen Collection: Vigorously swab or brush the base of the lesion with a sterile dry polyester, rayon, or Dacron swab. Collect a second swab from the same lesion. Insert both swabs into the sterile plastic aliquot tube or sleeve and break off the end of the swabs, if required, to tightly close the sample. More than one lesion should be sampled, preferably from different body sites. Store specimens in 4° C.

A combination of standard, contact, and droplet precautions should be applied in all healthcare settings when a patient presents with fever and vesicular/pustular rash. The patient should be placed in an isolation room (negative air-pressure if available). PPE should be donned before entering the patient’s room and disposed of prior to leaving the isolation room. PPE measures include: disposable gown and gloves, N95 (or comparable) filtering disposable respirator, and eye protection. For more information visit: Infection Control: Hospital | Monkeypox | Poxvirus | CDC.